Figure 2From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical doseBlood clearance (after tracer and therapeutic dose) and renal excretion for a group of five patients, who were administered 35 mCi (1295 MBq) of 188Re-HEDPBack to article page